AgomAb Therapeutics NV (AGMB) KPIs and segments
AGMBNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$5.97−0.39 (-6.13%)
Close on Nov 16, 2026Market cap $149.25KP/E –Yield –
KPIs & segments
Operating metrics and segments that drive AgomAb Therapeutics's business
Coming soon
This tab will track the numbers specific to AgomAb Therapeutics's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.
See a number that looks wrong?